SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Novartis India informs about details of loss of certificate

09 Feb 2024 Evaluate
Novartis India has enclosed intimation dated February 08, 2024 received from Link Intime India, Registrar and Transfer Agent, providing information regarding issue of duplicate share certificate in favour of shareholder of the Company. Further, in accordance with the SEBI Notification No. SEBI/LAD-NRO/GN/2022/66 dated January 24, 2022, read with SEBI Circular No. SEBI/HO/MIRSD/MIRSD_RTAMB/P/CIR/2022/8 dated January 25, 2022, letter of confirmation in lieu of the physical share certificate will be issued to the said shareholder of the Company within the prescribed timelines. Shareholder(s) Name: Kantilal Shamji Vora (Folio No. 02135680)

The above information is a part of company’s filings submitted to BSE.

Novartis Share Price

1050.70 12.60 (1.21%)
06-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Redington 223.40
Adani Enterprises 2539.40
Amrapali Industries 18.69
Rashi Peripheral 500.90
PDS 288.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×